Accelr8 Up 8 Percent on Patent News

Feb 03, 2005

NEW YORK, Feb. 3 (GenomeWeb News) - Shares in Accelr8 were up 7.95 percent, or $.21, at $2.85 in late-afternoon trading after the company said it won a US patent for its OptiChem surface chemistry.

The stock shot up to $3.35 in early-morning trade before settling down to $2.85 in unusually heavy volume.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

More Reproducible

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

To Catch the Swap

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

Face of the Suspect

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

This Week in Cell

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

Main menu